Healthcare & Life Science



Cross Border assisted Hyris to find partners funding a capital increase for the company’s growth, stimulating the interest of three international Venture Capital funds. Hyris was therefore able to choose Astanor Ventures as lead investor and obtain a greater commitment than initially expected for the round.

Cross Border prepared the fundraising documentation and assited Hyris in the due diligence and the negotiation of shareholders agreement and articles of association.